Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

33 recalls · Class III, newest first

Class III · Low risk

Enoxaparin Sodium

Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL

Terminated Labeling / mix-up Sanofi-Aventis U.S. LLC NDC 0955-1012-10 D-0153-2018
Class III · Low risk

Clofarabine injection

Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.

Terminated Labeling / mix-up Sanofi-Aventis U.S. LLC NDC 0955-1746-01 D-0056-2018
Class III · Low risk

Ampicillin for Injection

Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.

Terminated Labeling / mix-up Sandoz Inc NDC 0781-3407-78 D-1179-2017
Class III · Low risk

Mobic (meloxicam)

Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

Terminated Labeling / mix-up Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0030-01 D-0007-2018
Class III · Low risk

Obagi-C Rx System C-Therapy Night Cream

Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

Terminated Labeling / mix-up Valeant Pharmaceuticals North America LLC NDC 62032-222-02 D-0998-2017
Class III · Low risk

Walgreens Daytime and Nighttime Cold & Flu

Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the product twin pack. The incorrect product sleeve is for Day-Night Cold and Flu whereas the batch contains Day-Night Cough Liquid.

Terminated Labeling / mix-up L. Perrigo Company D-0925-2017
Class III · Low risk

Zinc Oxide Paste 25%

Labeling: Error on Declared Strength: Error is due to an incorrect value in the Drug Facts Panel. The correct strength is displayed on the primary container.

Terminated Labeling / mix-up Fagron, Inc NDC 51522-0694-5 D-0695-2017
Class III · Low risk

Ciclopirox Olamine Cream USP

Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.

Terminated Labeling / mix-up G & W Laboratories, Inc. NDC 0713-0638-15 D-0636-2017

Recalls by year